BioArctic AB is a pioneering brand that is revolutionizing treatments in neurodegenerative disorders. With a vision to improve the lives of patients with disorders of the central nervous system, BioArctic develops innovative drugs with the potential to transform the treatment of conditions like Alzheimer's disease, Parkinson's disease, and ALS. In addition to groundbreaking drug development, the brand also focuses on advanced technology that enables drugs to effectively cross the blood-brain barrier.

To maximize value creation, BioArctic collaborates closely with leading academic research groups and companies in the global pharmaceutical industry. With a commitment to sustainability, the brand adopts a responsible approach to its operations, including sustainable employeeship and the efficient use of resources. By pushing the boundaries of science and partnering with key stakeholders, BioArctic is dedicated to making a lasting impact on patients and advancing the field of neurodegenerative disorder treatments